The p53 homologue p73 eciently activates p53-responsive genes. The well documented over-expression of p73 spliced forms in a wide variety of tumor types promoted us to elucidate the mechanisms underlying p73-mediated transcription. Using the luciferase reporter gene driven by Mdm2-minimal promoter in p53 null cells, we demonstrate that the weak transcriptional activity mediated by p73a was increased by the mutant form p73b 292 , which by itself is transcriptionally inactive. Similarly, cooperation between p73b and an inactive form of p73a increased p73b-mediated transcriptional activities. Conversely, p73b elicited a silencing eect on a gain of function mutant, p53 281 , which by itself mediated ecient transactivation of the MDR promoter. Neither anisomycin nor actinomycin D altered p73-mediated transcriptional activities, whereas sorbitol profoundly inhibited them through a rapid proteasomedependent degradation of p73. Our observations point to plausible scenarios in which p73, through cooperation between p73 spliced forms and suppression of gain of function mutant p53 may elicit changes in the transcription of p53 target genes that play key roles in cell growth and death. Oncogene (2000) 19, 831 ± 835.
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The most frequently mutated human tumor suppressor gene, p53, has been implicated in control of cell growth and death (Levine, 1997; Oren and Prives 1996) . In most cases, p53 activities have been linked to its transcriptional activites via promoters of Mdm2, cyclin dependent kinase inhibitor p21 and several oxidative stress responsive genes (El-Diery et al., 1993; Polyak, 1997) . The recent identi®cation of p73 (Kaghad et al., 1997) , p51 (Osada et al., 1998) and p63 (Yang et al., 1998) , which structurally and functionally resemble p53, marked them as potential tumor suppressors belonging to the p53 family (reviewed by Oren, 1997; Kaelin, 1999) .
The p73 protein shares signi®cant homology with p53 within the activation, sequence speci®c DNA binding and oligomerization domains (Kaghad et al., 1997; Stenger et al., 1994) . Indeed, p73 is capable of activating the transcription of p53-responsive genes, and of inhibiting cell growth in a p53-like manner by inducing apoptosis (Jost et al., 1997) . Further, by disrupting the p73 association with p300/CBP, Mdm2 limits p73 transcriptional output; therefore, it plays a key role in regulating both p53 and p73 (Zeng et al., 1999; Dobbelstein et al., 1999) . However, the viral proteins HSV-E1B, SV40-LT and HPV-E6, which eciently inactivate p53, do not aect p73 stability or transcriptional activites (Marin et al., 1998; Prabhu et al., 1998; Roth et al., 1998; Steegenga et al., 1999) . The C-terminal portion present in the alpha isoform of p73, yet excluded from the b forms demonstrated the ability to in¯uence the protesome-dependent degradation of p73, highlighting one mechanism which aects availability and in turn activity of selective isoforms (Lee and La Thangue, 1999) .
In contrast to the frequent occurrence of p53 mutations, extensive search of colorectal (Sunahara et al., 1998) , bladder (Yokomizo et al., 1999a) , lung (Mai et al., 1998a) , prostate (Takahashi et al., 1998; Yokomizo et al., 1999b) oligodendrogliomas (Mai et al., 1998b) neuroblastoma (Kovalev et al., 1998) , melanoma (Tsao et al., 1999) and renal cell carcinoma (Mai et al., 1998c) did not identify p73 mutations (Han et al., 1999) . Conversely, tumors of lung, neuroblastoma and renal cell carcinoma were reported to exhibit elevated expression of p73, as well as the switch from monoallelic expression in normal tissue to biallelic expression in tumors (Mai et al., 1998a,b; Kovalev et al., 1998; Sunahara et al., 1998) . Further support for alternate regulation of p73 at the expression level comes from the identi®cation of multiple sliced forms of p73. The p73 gene is expressed as p73a, a 636 amino acid polypeptide, and p73b, a 499 amino acid polypeptide that is encoded by an alternatively spliced transcript lacking 96 nucleotides corresponding to exon 13 (Kaghad et al., 1997; Jost et al., 1997) . Two additional variants were recently reported: p73g, in which exon 11 is spliced out; and p73d, in which exons 11, 12 and 13 are spliced out. Wide variations have been reported in expression of the four spliced forms of p73 in human tumors (De Laurenzi et al., 1998) .
The increasing evidence for the simultaneous occurrence of alternate p73 spliced forms in the same cells and the possibility that selective p73 spliced forms interact in human tumors prompted us to elucidate mechanisms underlying transcriptional activities mediated by p73a and p73b. To monitor p73-mediated transcriptional activation we used the luciferase gene driven by minimal Mdm2 promoter sequences upon forced expression of p73a or p73b cDNAs in p53 null mouse ®broblast cells 10/1. Cotransfection of either p73a or p73b with Mdm2-Luc revealed low basal transcriptional activity for p73a, whereas p73b mediated about four times higher transcriptional activation of Mdm2 promoter ( Figure 1) . We explored the possible eect of interplay between p73 forms on p73-mediated transcriptional activities in light of current knowledge of the relationship between p53 oligomerization and its transcriptional activities (Stenger et al., 1994; Lomax et al., 1998) . To determine whether these p73 forms cooperate, we utilized wild type (wt) and mutant (transcriptionally inactive due to mutation at aa 292, which abolished DNA binding) forms of p73a and p73b. Co-transfection of p73a with p73a 292 did not lead to marked changes in low transcriptional activities mediated by p73a. However, co-transfection of p73b with the mutant form p73a 292 caused an additional 2.6-fold increase in Mdm2-driven transcriptional activities over levels seen by p73b alone. Similarly, co-transfection of p73a with the mutant form p73b 292 was sucient to further increase transcriptional activities an additional 2.3-fold over p73a alone. Increased transcriptional activities in all cases required that one of the p73 forms be in the wt con®guration (Figure 1 ). Interestingly, co-transfection of wt p73a and wt p73b resulted in transcriptional activation that was intermediate between p73a and p73b alone (Figure 1 ). These observations suggest that the additive eect seen when p73 mutant is co-expressed with its wt counterpart results from cooperation, whereas when both forms are expressed in the wt con®guration they may compete with one another and thus limit overall transcriptional output. To exclude the possibility that modest changes in p73-mediated transcriptional activity are not due to the saturating quantity of p73 constructs employed, these experiments were repeated using a ®ve times lower amount (at the same 1 : 1 ratio) of the respective plasmids, revealing a similar pattern of activities (data not shown). These observations suggest that cooperation between active and inactive forms of p73 eciently increase the overall degree of transactivation.
Exposure of the transfected cells to actinomycin D, UV-irradiation (data not shown), or anisomycin (Figure 2 ) did not signi®cantly change transcriptional activation mediated by p73a or p73b, which is in agreement with former studies (reviewed by Kaelin, 1999) . Unlike any of the other forms of stress tested in the present study, exposure of p73 transfected cells to sorbitol (0.6 M for 2 h), which causes hyperosmotic shock, led to a marked decrease (3.6-fold for p73a and 12.9-fold for p73b) in p73-mediated transcriptional activities (Figure 2 ). Decreased p73-mediated transcription coincided with a lower level of p73 expression (Figure 2) . The sorbitol-mediated-decrease in p73 expression transcriptional activity could be partially attenuated by maintaining the cells in the presence of the proteasome inhibitor MG132 (Figure 2) , suggesting that the ability to alter transcriptional activities mediated by p73 is limited to selective forms of stress via proteasome-mediated degradation of p73 proteins due to cellular exposure to sorbitol, the nature of which is yet to be determined.
In agreement with other studies (Zhu et al., 1998) , our observations suggest that of the two forms of p73, it is p73b that is more potent in trans-activating the Mdm2 promoter, which was used in the present study as a representative of p53 target sequences. Similar observations were made with p21 Waf promoter sequences (data not shown).
The observation of cooperation between wt and mutant forms of dierent p73 spliced forms led us to examine the possible eect of p73 on a gain of function mutant form of p53 which was shown to play an important role in altering tumor cells' ability to undergo growth arrest and apoptosis (Blandino et al., 1999; Dittmer et al., 1993; Lotem and Sachs, 1995; Gorgoulis et al., 1998; Gualberto et al., 1998; Harvey et al., 1995; Iwamoto et al., 1996; Smith et al., 1999) . Recent studies revealed that the p53 281G mutant elicits a gain of function through eective increase in transcriptional activities mediated by the MDR promoter (Lanyi et al., 1998) . Indeed, transfection of this mutant to 10/1 cells revealed markedly increased MDR-driven CAT activity (Figure 3a) . However, cotransfection of p53 281G with p73a or p73b lowered the level of p53 281G -mediated transcriptional activities, suggesting that p73a and more strikingly p73b suppress p53 gain of function activity (Figure 3a , compare bar 3 with bar 6 and bar 7). Conversely, p73b but not p73a was able to mediate an increase of p53 292 (as indicated in the ®gure) (Jost et al., 1997) . Protein extracts prepared 24 h after transfection were subjected to immunoblotting analysis to monitor the level of exogenous p73 expression using antibodies to HA epitope (HA11, BabCo). Immunoblots were carried out on 100 mg of whole cell extracts, and detection of antibody recognition was performed with Enhanced Chemiluminescence (Amersham). Equal amounts of cellular extracts were used for luciferase assays, which were carried out using a kit (Promega). In all cases the eciency of transfection was normalized with respect to b-Gal activities expression of p73b and wt p53 forms, reduced the level of Mdm2-driven transcription to a lower level than that seen with p73b alone (Figure 3b , compare lane 9 with 5). The latter implies that the wt forms of p73b and p53 compete with one another, whereas the gain of function mutant cooperates with p73b. The cooperation with p53 281G was not mediated by mutant forms of p73 (data not shown). These results suggest that over expression of p73 spliced forms, which is well documented in human tumors (De Laurenzi et al., 1998) , may serve to limit the degree of activity that would be otherwise mediated by the gain of function mutant p53 forms. Conversely, gain of function p53 mutant could alter the degree of p73-mediated transcriptional activities depending on the spliced form of p73 which is expressed. Accordingly, tumor cells that express p73b and a gain of function p53 mutant are expected to exhibit a higher degree of transcriptional activities of genes that would normally be regulated by wt p53. The ®nding that unlike p53, p73 is not aected by the viral proteins HPV-E6 and SV40-LT strengthens the ability to identify tumor cells in which p73 is expected to substitute, in part, for p53-elicited cellular regulatory functions.
While con®rming previous observations that p73b is a better transcriptional activator of certain promoters than p73a (Kaghad et al., 1997; Zhu et al., 1998) , our study points to a new mode of regulation of p73 activities via the example of sorbitol, which decreases p73-mediated transcription as a result of ecient degradation of the p73 protein. Sorbitol, a classic osmotic stress agent, may represent a subset of other compounds that alter p73 stability, and, in turn, p73 activity. While decreasing p73 stability, sorbitol increases p53 level and nuclear accumulation (Sugano et al., 1995) , suggesting divergent cellular responses to (Lanyi et al., 1998) as indicated in the ®gure. Proteins were prepared and analysed as indicated in the legend to Figure 1 , with the exception that the analysis of transcriptional activity was carried out using a kit for monitoring the levels of CAT proteins (CAT-ELISA, Boehringer Mannheim) dierent forms of stress by various members of the p53 family.
The present study also points to the possible implications of the interaction among dierent forms of p73. The fact that inactive forms of p73 can increase the degree of transcriptional activation mediated by the alternate p73 form suggests that: (i) p73 mediates better transcriptional activities as a heterodimer (ii) It is sucient for p73 to mediate strong transcriptional activities with one functional DNA binding domain. (iii) The overall output of p73 transcriptional activities may be regulated by the amounts of the respective forms expressed at any given time; this, in turn, suggests that p73-mediated transcriptional activities are expected to vary in cells that express dierent levels and forms of p73, as shown for certain tumor cells (De Laurenzi et al., 1998) . (iv) Given the homology between the p73 and p53 oligomerization domains, it is possible that certain forms of p73 would heterodimerize with selective forms of wt and/or mutant forms of p53. The latter may serve as a putative mechanism for altering transcriptional activities of gain of function mutant p53 forms, as shown here for p53 281G .
Although our studies were con®ned to the Mdm2 and p21 waf (not shown) promoter sequences, it is likely that the interplay between dierent forms or cooperation with other p53 family members would generate and transmit dierent transactivation signals to various promoter sequences. The latter notion is supported by the observation that p53, p73a, and p73b dier in the ability to activate clusters of p53-regulated genes, including GADD45, BAX, 14-3-3, and p85 (Zhu et al., 1998; Di Como et al., 1999) .
In identifying the contribution of p73 cooperation and the eect of p73 on p53 gain of function mutant in p73 transcriptional activities, our studies point to possible mechanisms by which alternatively spliced and selectively expressed forms of p73 may alter patterns of gene expression in response to selective forms of stress as well as in human tumors.
